Transcription factor activity could potentially shape the differential gene expression landscapes observed across GBM subtypes in one of three ways: (i) through altered TF expression per se, (ii) through differential regulatory strength and directionality (manifested as altered F values), or (iii) a combination of these two mechanisms. This evidence concerns the gene TF and glioblastoma.